Jehan S. Perera

Jehan S. Perera

Auto-generated profile, based on publicly available information

Jehan S. Perera

Department of Chemistry University of Alabama at Birmingham Birmingham Alabama USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2026 in Small Science
Verified
Journal Article
Open access
BMB. D. Imansha Madhushan
B. D. Imansha Madhushan
AOAdrianna L. Orsi
Adrianna L. Orsi
JPJehan S. Perera
Jehan S. Perera
JPJennifer M. Pyles
Jennifer M. Pyles
CLChristine C. Lawrence
Christine C. Lawrence
JBJonathan Burns
Jonathan Burns
The ion exchange behavior of K‐ and Cs‐derivatives of α‐zirconium phosphate, A‐ZrP, with the targeted alpha therapy (TAT) radionuclide 211 At, as At + and AtO + , has been investigated. The K‐ZrP shows strong affinity for both At + and AtO + , ≥99% uptake. The affinity to Cs‐ZrP was less pronounced, 87%–94% uptake, favoring At + . The binding strength was tested against several leaching solutions, including carbonate, phosphate buffered saline (PBS), 4‐(2‐hydroxyethyl)‐1‐piperazineethanesulfonic acid (HEPES) buffers, and ethylenediaminetetraacetic acid (EDTA) solutions at various concentrations (0.1–10 mM). K‐ZrP retained 211 At in all buffer and EDTA solutions up to 1 mM (<0.5% leaching). The Cs‐ZrP showed no leaching of At + , while AtO + leached (1%–3%) in the carbonate and HEPES buffers, along with all of the EDTA solutions, with complete retention only in the PBS buffer. In all cases, when the EDTA concentration reached 10 mM, 211 At leaching was observed. Once incorporated into the ZrP nanoplatelets, significant shielding of the α‐particles was observed, not only attenuating the intensity of the emission but also reducing the energy of the α‐particles themselves exiting the nanoplatelets. These properties provide the basis for K‐ZrP, and to a lesser extent, Cs‐ZrP to be further considered as potentially promising candidates for a delivery mechanism of 211 At for application in TAT.